Basilea Pharmaceutica (XSWX:BSLN) Days Payable : 53.18 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica Days Payable?

Basilea Pharmaceutica's average Accounts Payable for the six months ended in Dec. 2023 was CHF4.9 Mil. Basilea Pharmaceutica's Cost of Goods Sold for the six months ended in Dec. 2023 was CHF16.8 Mil. Hence, Basilea Pharmaceutica's Days Payable for the six months ended in Dec. 2023 was 53.18.

The historical rank and industry rank for Basilea Pharmaceutica's Days Payable or its related term are showing as below:

XSWX:BSLN' s Days Payable Range Over the Past 10 Years
Min: 41.13 Med: 112.99 Max: 180.2
Current: 45.32

During the past 13 years, Basilea Pharmaceutica's highest Days Payable was 180.20. The lowest was 41.13. And the median was 112.99.

XSWX:BSLN's Days Payable is ranked worse than
75.45% of 717 companies
in the Biotechnology industry
Industry Median: 147.46 vs XSWX:BSLN: 45.32

Basilea Pharmaceutica's Days Payable increased from Dec. 2022 (46.14) to Dec. 2023 (53.18). It may suggest that Basilea Pharmaceutica delayed paying its suppliers.

Basilea Pharmaceutica Days Payable Historical Data

The historical data trend for Basilea Pharmaceutica's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Days Payable Chart

Basilea Pharmaceutica Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

127.33

151.10

180.20

80.17

41.13

Basilea Pharmaceutica Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															138.38	93.72	46.14	37.73	53.18

Competitive Comparison of Basilea Pharmaceutica's Days Payable

For the Biotechnology subindustry, Basilea Pharmaceutica's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Basilea Pharmaceutica's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Basilea Pharmaceutica's Days Payable distribution charts can be found below:

* The bar in red indicates where Basilea Pharmaceutica's Days Payable falls into.

Basilea Pharmaceutica Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Basilea Pharmaceutica's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.191	+	5.847)	/	2 )	/	26.794	*	365
=	3.019					/	26.794	*	365
=	41.13

Basilea Pharmaceutica's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (3.942	+	5.847)	/	2 )	/	16.798	*	365 / 2
=	4.8945					/	16.798	*	365 / 2
=	53.18

Basilea Pharmaceutica Days Payable Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Basilea Pharmaceutica (XSWX:BSLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

BSLNz:UK

Address

Switzerland Innovation Park, Basel Area, Main Campus, Near Basel, Allschwil, CHE, 4058

Website

https://www.basilea.com

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica (XSWX:BSLN) Headlines

No Headlines